Published in Thromb Haemost on July 12, 1991
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest (1996) 2.96
Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest (1998) 2.19
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A (1995) 1.98
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A (1999) 1.96
Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma (2009) 1.76
Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest (1998) 1.58
Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1. Circ Res (2008) 1.55
Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest (1995) 1.52
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol (2000) 1.48
Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol (1993) 1.45
Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci U S A (1998) 1.44
Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol (1994) 1.42
The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax (2007) 1.41
Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med (2005) 1.33
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A (2002) 1.31
The role of tissue factor and factor VIIa in hemostasis. Anesth Analg (2009) 1.31
Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest (1996) 1.29
Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J (1995) 1.27
Tissue factor expression during human and mouse development. Am J Pathol (1996) 1.19
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol (2000) 1.18
Tissue factor and thrombosis: The clot starts here. Thromb Haemost (2010) 1.16
Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor. J Thromb Haemost (2009) 1.15
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res (2006) 1.13
Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest (1993) 1.12
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci (2004) 1.12
Interplay between coagulation and vascular inflammation in sickle cell disease. Br J Haematol (2013) 1.12
Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A (1999) 1.08
Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun (1999) 1.08
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol (2000) 1.08
Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res (2009) 1.04
Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest (1993) 1.04
The tissue factor requirement in blood coagulation. J Biol Chem (2005) 1.03
Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest (1993) 0.98
Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. J Exp Clin Cancer Res (2011) 0.94
Cellular localization of thrombomodulin in human epithelium and squamous malignancies. Am J Pathol (1995) 0.92
Grateloupia longifolia polysaccharide inhibits angiogenesis by downregulating tissue factor expression in HMEC-1 endothelial cells. Br J Pharmacol (2006) 0.91
The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Am J Pathol (1997) 0.89
Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J (1996) 0.88
Thrombosis in systemic lupus erythematosus: a review article. ISRN Rheumatol (2012) 0.87
In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy. Am J Pathol (1999) 0.86
In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes. Am J Pathol (1994) 0.85
Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Gut (1998) 0.85
Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J Clin Invest (2000) 0.84
Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia. J Natl Med Assoc (2006) 0.84
Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas. Mol Med (1995) 0.84
Expression of tissue factor is increased in astrocytes within the central nervous system during persistent infection with borna disease virus. J Virol (1996) 0.82
Endometriosis and tissue factor. Ann N Y Acad Sci (2008) 0.81
Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIa. Biochem J (1996) 0.81
Elevation of plasma tissue factor levels in patients with severe acute pancreatitis. J Gastroenterol (2006) 0.81
In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis. J Thromb Haemost (2006) 0.80
Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa. Proteins (2009) 0.80
Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol (1995) 0.78
Targeted Nanotherapies for the Treatment of Surgical Diseases. Ann Surg (2016) 0.78
Association between the molecular pathobiology of essential hypertension and thrombotic diseases. Am J Pathol (2000) 0.78
Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model. Thromb Res (2011) 0.77
Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury. J Transl Med (2015) 0.77
Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines. Am J Vet Res (2017) 0.75
Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides. Biochem J (1993) 0.75
Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2. Inflammation (2015) 0.75
Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology. J Interv Card Electrophysiol (2001) 0.75
LPS induction of gene expression in human monocytes. Cell Signal (2001) 7.61
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol (2000) 3.96
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun (1986) 3.94
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene (2006) 3.89
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology (1998) 3.82
Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem (1979) 3.61
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
Secretion of haemolysin by Escherichia coli. Curr Top Microbiol Immunol (1986) 3.21
Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med (2000) 2.79
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Role of tissue factor in embryonic blood vessel development. Nature (1996) 2.54
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
FDP-activation of yeast pyruvate kinase. Biochem Biophys Res Commun (1966) 2.40
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry (1989) 2.29
Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol (1988) 2.28
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest (1998) 2.19
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med (1991) 2.10
Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci U S A (2000) 2.10
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A (2001) 2.07
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem (1980) 2.05
The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. Mol Gen Genet (1986) 2.02
Characterisation of HlyC and mechanism of activation and secretion of haemolysin from E. coli 2001. FEBS Lett (1985) 2.01
Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res (1988) 2.00
Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation (1998) 1.95
Genetical and functional organisation of the Escherichia coli haemolysin determinant 2001. Mol Gen Genet (1985) 1.92
Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem J (1985) 1.92
Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med (1980) 1.90
Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem (1994) 1.90
Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest (1998) 1.89
The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem (1988) 1.89
Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol (1997) 1.82
Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice. J Immunol (1977) 1.82
Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem (1982) 1.80
Functional characterization of a cloned haemolysin determinant from E. coli of human origin, encoding information for the secretion of a 107K polypeptide. Mol Gen Genet (1984) 1.75
Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest (1998) 1.73
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost (2008) 1.70
Role of cardiac myocyte tissue factor in heart hemostasis. J Thromb Haemost (2007) 1.68
Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem (1991) 1.67
Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J Exp Med (1975) 1.66
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Secretion of a 107 K dalton polypeptide into the medium from a haemolytic E. coli K12 strain. Mol Gen Genet (1984) 1.62
Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med (1981) 1.62
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol (1989) 1.61
Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes. Biochim Biophys Acta (1987) 1.61
The assessment by immunofluorescence methods of humoral anti-myelin antibodies in man. J Immunol (1970) 1.61
A novel C-terminal signal sequence targets Escherichia coli haemolysin directly to the medium. J Cell Sci Suppl (1989) 1.60
Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med (1983) 1.60
Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem (1999) 1.60
Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A (1998) 1.57
Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci U S A (1993) 1.55
Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J Biol Chem (1996) 1.55
Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem (1996) 1.55
Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med (1975) 1.54
The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem (1991) 1.54
Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition. J Thromb Haemost (2015) 1.54
The C-terminal, 23 kDa peptide of E. coli haemolysin 2001 contains all the information necessary for its secretion by the haemolysin (Hly) export machinery. FEBS Lett (1986) 1.54
Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. J Clin Invest (1980) 1.53
Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med (1982) 1.53
Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci U S A (1999) 1.53
Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest (1995) 1.52
Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J Immunol (1993) 1.52
A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol (1998) 1.51
A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release (2006) 1.51
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem (1990) 1.49
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol (2000) 1.48
Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol (1976) 1.48
Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol (1989) 1.48
Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation (1997) 1.47
Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. J Immunol (1971) 1.47
Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost (2009) 1.46
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci U S A (1988) 1.44
Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol (1995) 1.44
Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci (2000) 1.44
Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol (1991) 1.44
Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci U S A (1996) 1.44
Glomerular complement components in human glomerulonephritis. J Clin Invest (1974) 1.43
Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol (1994) 1.42
Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol (1996) 1.41
Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol (2001) 1.41
Defense. FASEB J (1994) 1.39
Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood (2001) 1.37
An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest (1975) 1.36
Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol (1986) 1.36